Evidence map›Paper›PMID 29643355›Full record

ArticleTranslational psychiatry2018

Reverse translated and gold standard continuous performance tests predict global cognitive performance in schizophrenia.

Andrew W Bismark, Michael L Thomas, Melissa Tarasenko, Alexandra L Shiluk, Sonia Y Rackelmann, Jared W Young, Gregory A Light

Open access · goldAbstract read
In one paragraph

Article in Translational psychiatry, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.9field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 15 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Andrew W BismarkVISN-22 Mental Illness Research Education and Clinical Center (MIRECC), VA San Diego Healthcare System, San Diego, USA.
Michael L ThomasDepartment of Psychiatry, University of California, San Diego, USA.
Melissa TarasenkoVISN-22 Mental Illness Research Education and Clinical Center (MIRECC), VA San Diego Healthcare System, San Diego, USA.
Alexandra L ShilukDepartment of Psychiatry, University of California, San Diego, USA.
Sonia Y RackelmannDepartment of Psychiatry, University of California, San Diego, USA.
Jared W YoungVISN-22 Mental Illness Research Education and Clinical Center (MIRECC), VA San Diego Healthcare System, San Diego, USA. jaredyoung@ucsd.edu.
Gregory A LightVISN-22 Mental Illness Research Education and Clinical Center (MIRECC), VA San Diego Healthcare System, San Diego, USA.
University of California, San Diego · USMental Illness Research, Education and Clinical Centers · USVA San Diego Healthcare System · US

Funding

A model organism of brain circuitry and behavioral switching for bipolar disorderR01MH104344 · NIMH · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI YOUNG, JARED WILLIAM · 2014 to 2017
$1.7M
Neurophysiological biomarkers of behavioral dimensions from cross-species paradigmsUH2MH109168 · NIMH · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI YOUNG, JARED WILLIAM · 2016 to 2017
$993k
Neuroimaging and Neurocognitive Computerized Adaptive Testing in SchizophreniaK23MH102420 · NIMH · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI THOMAS, MICHAEL L · 2014 to 2018
$815k
NIMH NIH HHS K23 MH102420NIMH NIH HHS R01 MH104344NIMH NIH HHS UH2 MH109168
6 · The paper itself

Abstract

Attentional dysfunction contributes to functional impairments in schizophrenia (SZ). Sustained attention is typically assessed via continuous performance tasks (CPTs), though many CPTs have limited cross-species translational validity and place demands on additional cognitive domains. A reverse-translated 5-Choice Continuous Performance Task (5C-CPT) for human testing-originally developed for use in rodents-was designed to minimize demands on perceptual, visual learning, processing speed, or working memory functions. To-date, no studies have validated the 5C-CPT against gold standard attentional measures nor evaluated how 5C-CPT scores relate to cognition in SZ. Here we examined the relationship between the 5C-CPT and the CPT-Identical Pairs (CPT-IP), an established and psychometrically robust measure of vigilance from the MATRICS Consensus Cognitive Battery (MCCB) in a sample of SZ patients (n = 35). Relationships to global and individual subdomains of cognition were also assessed. 5C-CPT and CPT-IP measures of performance (d-prime) were strongly correlated (r = 0.60). In a regression model, the 5C-CPT and CPT-IP collectively accounted for 54% of the total variance in MCCB total scores, and 27.6% of overall cognitive variance was shared between the 5C-CPT and CPT-IP. These results indicate that the reverse translated 5C-CPT and the gold standard CPT-IP index a common attentional construct that also significantly overlaps with variance in general cognitive performance. The use of simple, cross-species validated behavioral indices of attentional/cognitive functioning such as the 5C-CPT could accelerate the development of novel generalized pro-cognitive therapeutics for SZ and related neuropsychiatric disorders.

Indexed as

AttentionCognitionSchizophrenic PsychologyAdultFemaleHumansMaleMiddle AgedNeuropsychological TestsSchizophreniaYoung Adult

Identifiers

PMID29643355
PMCPMC5895589
OpenAlexW2796499562

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.